BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND KDM6A, O15550, UTX, 7403, ENSG00000147050, DKFZp686A03225, RP13-886N14_3, MGC141941, bA386N14_2 AND Treatment
36820 results:

  • 1. Artemisinin Confers Cytoprotection toward Hydrogen Peroxide-Induced Cell Apoptosis in Retinal Pigment Epithelial Cells in Correlation with the Increased Acetylation of Histone H4 at Lysine 8.
    Yang C; Ge L; Yu X; Lazarovici P; Zheng W
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675608
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
    Elbert M; Neumann F; Kiefer M; Christofyllakis K; Balensiefer B; Kos I; Carbon G; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Fend F; Bonzheim I; Thurner L; Bewarder M
    Sci Rep; 2024 Apr; 14(1):9571. PubMed ID: 38671086
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
    Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
    Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report.
    Guo Y; Li J; Li M; Li Z; Cui Y; Li Y; Zhao R; Han Q; Yang H; Ma C
    Medicine (Baltimore); 2024 Apr; 103(17):e37923. PubMed ID: 38669361
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center.
    Hao Z; Fei Y; Chen J; Huang S; Wang L; Yu Y; Bian M; Si Y; Zhang X; Yang X; Zhang B; Wan Y; Zhang Y; Lin G
    Hematology; 2024 Dec; 29(1):2344998. PubMed ID: 38666535
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis.
    Li J; Cai Q; Wang Z; Wang L; Yang G; Zhang Z; Ge N; Hu S; Bai T
    Discov Med; 2024 Apr; 36(183):666-677. PubMed ID: 38665016
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up.
    Maggio E; Bauci F; Polito A; Arena F; Pertile G
    BMC Ophthalmol; 2024 Apr; 24(1):194. PubMed ID: 38664667
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia.
    Wu X; Cao Z; Chen Z; Wang Y; He H; Xiao P; Hu S; Lu J; Li B
    Clin Exp Med; 2024 Apr; 24(1):87. PubMed ID: 38662121
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
    Lee LJ; Han CJ; Saligan L; Wallen GR
    Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Real-life study on the use of response adapted therapy in patients with Hodgkin lymphoma: Results from a multicenter experience.
    Zilioli VR; Cencini E; Lorenzo S; Pezzullo L; Merli M; Rivellini F; Muzi C; Emiliano B; Marcheselli L; Luminari S
    Hematol Oncol; 2024 May; 42(3):e3273. PubMed ID: 38661120
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Research Progress of Targeted Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic lymphoma --Review].
    Chen D; Wang MY; Tian C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):643-646. PubMed ID: 38660880
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Inhibition of Autophagy Augments the Anticancer Activity of KPT-330 in Mantle Cell lymphoma Cells].
    Zhang YL; Chen YH; Zheng RJ; Zheng KJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):470-475. PubMed ID: 38660854
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Correlation Analysis of Peripheral Blood B Cell Count with Clinical Features and Prognosis in Patients Newly Diagnosed with Diffuse Large B-Cell lymphoma].
    Lu T; Mi H; Zhao DD; Yang SG; Bu YW; Zhang F; Chen WM; Sun DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):458-465. PubMed ID: 38660852
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and Prognosis of Non-Hodgkin's lymphoma].
    Zhao ZF; Hao XJ; Yang YM; Xu WG; Zhang YX; Yuan XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):434-438. PubMed ID: 38660848
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [A Real-World Single-Center Study of Adult Hodgkin's lymphoma].
    Wang LL; Tian L; Dong F; Yang P; Wan W; Li QH; Ma L; Gao JJ; Wang JJ; Zhao W; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):428-433. PubMed ID: 38660847
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line
    Valizadeh Toosi SM; Feyzi S; Kazemi A
    Korean J Gastroenterol; 2024 Apr; 83(4):150-156. PubMed ID: 38659251
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
    Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
    JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Breast mucosa-associated lymphoid tissue lymphoma: A case report and literature review.
    Luo S; Zhang X; Wang Z
    Medicine (Baltimore); 2024 Apr; 103(16):e37895. PubMed ID: 38640287
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.
    Wang H; Feng J; Liu Y; Qian Z; Gao D; Ran X; Zhou H; Liu L; Wang B; Fang M; Zhou H; Huang Z; Tao S; Chen Z; Su L; Su H; Yang Y; Xie X; Wu H; Sun P; Hu G; Liang A; Li Z
    Signal Transduct Target Ther; 2024 Apr; 9(1):99. PubMed ID: 38627366
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Chronic Lymphocytic Leukemia/Small Lymphocytic lymphoma, Version 2.2024.
    Wierda WG; Brown J; Abramson JS; Awan F; Bilgrami SF; Bociek G; Brander D; Cortese M; Cripe L; Davis RS; Eradat H; Fakhri B; Fletcher CD; Gaballa S; Hamid MS; Hill B; Kaesberg P; Kahl B; Kamdar M; Kipps TJ; Ma S; Mosse C; Nakhoda S; Parikh S; Schorr A; Schuster S; Seshadri M; Siddiqi T; Stephens DM; Thompson M; Ujjani C; Valdez R; Wagner-Johnston N; Woyach JA; Sundar H; Dwyer M
    J Natl Compr Canc Netw; 2024 Apr; 22(3):175-204. PubMed ID: 38626800
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1841.